原发性睾丸弥漫性大B细胞淋巴瘤中致癌性MYD88和CD79B突变的高发生率。 - Suppr

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

作者信息

Kraan W, van Keimpema M, Horlings H M, Schilder-Tol E J M, Oud M E C M, Noorduyn L A, Kluin P M, Kersten M J, Spaargaren M, Pals S T

机构信息

Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Pathology Laboratory, Dordrecht, The Netherlands.

出版信息

Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20.

DOI:10.1038/leu.2013.348

PMID:24253023

Abstract

摘要

相似文献

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

Leukemia. 2014 Mar;28(3):719-20. doi: 10.1038/leu.2013.348. Epub 2013 Nov 20.

Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.

Leuk Lymphoma. 2018 May;59(5):1260-1263. doi: 10.1080/10428194.2017.1370546. Epub 2017 Sep 3.

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.

Cancer. 2017 Apr 1;123(7):1166-1173. doi: 10.1002/cncr.30404. Epub 2016 Dec 4.

High prevalence of and mutations in intravascular large B-cell lymphoma.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7.

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.

Blood Cancer J. 2014 Dec 12;4(12):e266. doi: 10.1038/bcj.2014.87.

Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations.

Leuk Lymphoma. 2015 Jul;56(7):2141-5. doi: 10.3109/10428194.2014.979413. Epub 2015 Jan 14.

Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.

Neuropathology. 2017 Dec;37(6):509-516. doi: 10.1111/neup.12405. Epub 2017 Aug 30.

Morphologic Patterns and the Correlation With MYD88 L265P, CD79B Mutations in Primary Adrenal Diffuse Large B-Cell Lymphoma.

Am J Surg Pathol. 2020 Apr;44(4):444-455. doi: 10.1097/PAS.0000000000001386.

MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.

Appl Immunohistochem Mol Morphol. 2019 Apr;27(4):311-318. doi: 10.1097/PAI.0000000000000585.

Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.

Appl Immunohistochem Mol Morphol. 2020 Sep;28(8):e68-e71. doi: 10.1097/PAI.0000000000000655.

引用本文的文献

Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma.

J Transl Med. 2025 Jun 5;23(1):630. doi: 10.1186/s12967-025-06567-3.

A Rare Case of Adrenal Intravascular Large B-Cell Lymphoma Diagnosed via Percutaneous Needle Biopsy.

World J Surg Oncol. 2025 May 23;23(1):200. doi: 10.1186/s12957-025-03855-6.

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

Cancer Commun (Lond). 2025 Aug;45(8):919-935. doi: 10.1002/cac2.70033. Epub 2025 May 8.

High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.

Blood Cancer Discov. 2025 May 5;6(3):191-202. doi: 10.1158/2643-3230.BCD-24-0156.

Clinicopathological and genetic analyses of thyroid large B-cell lymphoma in a Japanese population.

J Clin Exp Hematop. 2024 Dec 25;64(4):286-291. doi: 10.3960/jslrt.24010. Epub 2024 Oct 28.

Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.

Eur J Haematol. 2025 Jan;114(1):186-194. doi: 10.1111/ejh.14325. Epub 2024 Oct 12.

Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL.

Hemasphere. 2024 Oct 7;8(10):e70024. doi: 10.1002/hem3.70024. eCollection 2024 Oct.

Next-generation sequencing of primary testicular lymphoma and relapse in the glans penis after prophylactic radiation therapy: a rare case report.

Diagn Pathol. 2024 Jun 3;19(1):72. doi: 10.1186/s13000-024-01498-x.

New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications.

Int J Hematol. 2025 Mar;121(3):331-341. doi: 10.1007/s12185-024-03781-5. Epub 2024 May 28.

Genomic landscape and distinct molecular subtypes of primary testicular lymphoma.

J Transl Med. 2024 May 1;22(1):414. doi: 10.1186/s12967-024-05140-8.

本文引用的文献

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.

Blood Cancer J. 2013 Sep 6;3(9):e139. doi: 10.1038/bcj.2013.28.

The genetic basis of diffuse large B-cell lymphoma.

Curr Opin Hematol. 2013 Jul;20(4):336-44. doi: 10.1097/MOH.0b013e3283623d7f.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.

Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas.

Clin Cancer Res. 2012 Oct 1;18(19):5203-11. doi: 10.1158/1078-0432.CCR-12-0845. Epub 2012 Jul 26.

Primary testicular lymphoma.

Clin Oncol (R Coll Radiol). 2012 Jun;24(5):358-65. doi: 10.1016/j.clon.2012.02.005. Epub 2012 Mar 17.

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.

Blood. 2012 Mar 15;119(11):2590-4. doi: 10.1182/blood-2011-11-390989. Epub 2012 Jan 25.

Pathogenesis of human B cell lymphomas.

Annu Rev Immunol. 2012;30:565-610. doi: 10.1146/annurev-immunol-020711-075027. Epub 2012 Jan 6.

Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.

Acta Neuropathol. 2011 Dec;122(6):791-2. doi: 10.1007/s00401-011-0891-2. Epub 2011 Oct 22.

First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.

J Clin Oncol. 2011 Jul 10;29(20):2766-72. doi: 10.1200/JCO.2010.31.4187. Epub 2011 Jun 6.

Oncogenically active MYD88 mutations in human lymphoma.

Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献